No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹253.6Prev. Close
₹258.55Turnover(Lac.)
₹56.73Day's High
₹259Day's Low
₹25252 Week's High
₹329.752 Week's Low
₹161.5Book Value
₹34.88Face Value
₹10Mkt Cap (₹ Cr.)
894.8P/E
13.85EPS
18.51Divi. Yield
026 Aug 2025
12:00 AM
AGM
Announcement Date: 26 Aug, 2025
12 Dec 2025
12:00 AM
BookCloser
28 Jan 2026
12:00 AM
Board Meeting
Agenda : Audited Result
10 Dec 2025
12:00 AM
EGM
The ANVISA certificate will be valid until May 12, 2027, provided that the applicable GMPs continue to be observed.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 38.77 | 38.75 | 32.71 | 32.67 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 20.5 | -10.8 | -39.96 | -30.48 |
Net Worth | 59.27 | 27.95 | -7.25 | 2.19 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 392.51 | 367.45 | 371.66 | 433.8 |
yoy growth (%) | 6.82 | -1.13 | -14.32 | 2.49 |
Raw materials | -217.14 | -175.73 | -174.09 | -196.97 |
As % of sales | 55.32 | 47.82 | 46.84 | 45.4 |
Employee costs | -64.14 | -67.47 | -87.32 | -87.77 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -12.4 | -17.96 | -32.36 | 62.4 |
Depreciation | -9.75 | -9.68 | -10.3 | -10.31 |
Tax paid | -0.2 | -0.2 | 0.37 | -0.38 |
Working capital | -11.56 | -7.53 | -58.84 | -73.01 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 6.82 | -1.13 | -14.32 | 2.49 |
Op profit growth | -23.14 | -134.75 | -464.11 | -42.95 |
EBIT growth | -28.4 | -1,016.65 | -101.66 | 294.25 |
Net profit growth | -119.55 | -301.52 | -151.57 | -981.55 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 599.51 | 575.65 | 499.65 | 511.19 | 392.52 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 599.51 | 575.65 | 499.65 | 511.19 | 392.52 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 3.49 | 28.55 | 0.91 | 77.88 | 2.4 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,878.2 | 102.43 | 4,47,032.09 | 705.44 | 0.86 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,760.5 | 71.43 | 1,83,758.68 | 598 | 0.43 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,405.7 | 66.81 | 1,49,223.98 | 577 | 0.14 | 2,547 | 249.82 |
Cipla Ltd CIPLA | 1,432.1 | 31.4 | 1,16,211.65 | 384.64 | 0.9 | 3,840.92 | 423.39 |
Dr Reddys Laboratories Ltd DRREDDY | 1,336.7 | 33.77 | 1,08,739.11 | -219.4 | 0.61 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
E D & Wholetime Director
K Chandran
WTD & Executive Director
Mohan Kumar Rayana
Independent Non Exe. Director
Anupam Vaidya
Independent Non Exe. Director
Mridul Sumanlal Mehta
Independent Non Exe. Director
MANOJKUMAR KHUBCHAND GURSAHANI
Independent Non Exe. Director
Pallavur Sankar Dass Vaidyanathan
Company Sec. & Compli. Officer
Jitendra J Gandhi
BSEL Tech Park B-Wing 10th Flr,
Sector 30 A Opp Vashi Rly Stat,
Maharashtra - 400703
Tel: 91-22-67942222
Website: http://www.wanbury.com
Email: shares@wanbury.com; jitendra.gandhi@wanbury.com
9 ShivShakti Indl Es,
J R Boricha Marg, Lower Parel,
Mumbai - 400 011
Tel: 022- 23016761 / 2301
Website: www.purvashare.com
Email: support@purvashare.com
Summary
Wanbury Limited, formerly known Pearl Organics Limited was incorporated in August, 1988. The Company attained its present name in September 2004. The Company is engaged in the business of pharmaceutic...
Read More
Reports by Wanbury Ltd
What is the Wanbury Ltd share price today?
What is the Market Cap of Wanbury Ltd?
What is the PE and PB ratio of Wanbury Ltd?
What is the 52 Week High and Low of Wanbury Ltd?
What is the CAGR of Wanbury Ltd?
What is the shareholding pattern of Wanbury Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
